Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Psychiatry Clear all

Conditions: Depression, Panic Disorder, Generalized Anxiety Disorder, Post-Traumatic Stress Disorder, Obsessive Compulsive Disorder (OCD)
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,431 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder, Other Specified Feeding or Eating Disorder
Interventions: Eating Disorder Dynamic Intervention; Behavioral
Lead sponsor: Trustees of Dartmouth College; Other
Eligibility: 18 Years to 70 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Psychiatry
Interventions: Not listed
Lead sponsor: Creighton University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Treatment Resistant Depression, Major Depressive Disorder, Analgesia, Ketamine, Peripheral Nervous System Agents, Central Nervous System Depressants, Neurotransmitter Agents, Anti-Inflammatory Agents, Physiological Effects of Drugs, Sensory System Agents, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Depressive Symptoms
Interventions: VTS-K; Drug
Lead sponsor: Theresa Jacob, PhD, MPH; Other
Eligibility: 18 Years to 89 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Obsessive Compulsive Disorder, Major Depressive Disorder, Anxiety
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 8 Years to 20 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Schizophrenia Spectrum Disorders, Cannabis Use
Interventions: Cannabidiol (CBD), Placebo; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 35 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2050
U.S. locations: 3
States / cities: Los Angeles, California • Baltimore, Maryland • Catonsville, Maryland

Conditions: Cardiovascular Diseases, Metabolic Syndrome, Obesity, Prediabetes, Mental Health Disorders, Endocrine Dysfunction, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease (CKD)
Interventions: Blood Work; Other
Lead sponsor: Clindove Research LLC; Other
Eligibility: 18 Years and older
Enrollment: 7,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Sleep Initiation and Maintenance Disorders, Depression
Interventions: Eszopiclone, Fluoxetine, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Emergency Services, Psychiatric
Interventions: mobile crisis team; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Dementia
Interventions: Depakote; Drug
Lead sponsor: Hearthstone Alzheimer Care; Industry
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Hopkinton, Massachusetts

Conditions: Depressive Disorder, Anxiety, Adolescent
Interventions: Breathing Intervention; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Albert Lea, Minnesota • Eau Claire, Wisconsin

Conditions: Stress Disorders, Post-Traumatic, PTSD, Animal-Human Bonding, Combat Stress Disorders
Interventions: Psychiatric Service Dog, Prolonged Exposure Therapy; Other · Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Tourette Syndrome, Obsessive Compulsive Disorder
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 12 Years to 45 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1988
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Depersonalization Disorder
Interventions: fluoxetine; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Traumatic Brain Injury, Suicidality
Interventions: Not listed
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Traumatic Brain Injury
Interventions: Not listed
Lead sponsor: VA Eastern Colorado Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 1,810 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Mental Health Disorder, Suicide Attempt, Suicidal Ideation, Emergency Psychiatric
Interventions: Improving Care, Accelerating Recovery & Education (ICARE); Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 12 Years to 17 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Burlington, Vermont

Conditions: Diagnosis, Dual (Psychiatry), Psychiatric Diagnosis, Drug Use Disorders
Interventions: Adherence Feedback (AF), AF + Contingency Management (AF + CM), AF + Motivational Enhancement Therapy (AF + MET); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Schizophrenia, Schizoaffective, Bipolar Disorder, Stress Disorders, Post-traumatic, Psychotic Disorders
Interventions: Psychiatric Advance Directives intervention; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bipolar Disorder, Schizophrenia
Interventions: Digital Health Feedback System; Other
Lead sponsor: Proteus Digital Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Boston, Massachusetts • Glen Oaks, New York

Conditions: Depression, Treatment Resistant Depression
Interventions: clinical assessments; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 85 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Criminal Behavior, Criminal Recidivism, Psychosocial Functioning
Interventions: Dialectical Behavior Therapy for Justice-Involved Veterans, Supportive Group Psychotherapy for Justice-Involved Veterans; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • The Bronx, New York

Conditions: Brain Injury
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 2
States / cities: Galveston, Texas

Search by objective public record fields.

Evaluating the Effects of Stress in Pregnancy

Eating Disorder Dynamic Intervention

Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

Improving Sleep and Psychological Functioning in People With Depression and Insomnia

Emergency Linkage to Outpatient Psychiatric Services

Study of Depakote for Behavioral and Psychological Symptoms in Dementia

Enhancing Brain And Mental Health Through Breathing Practice

Service Dogs and Prolonged Exposure Therapy for Military-Connected PTSD

Study of the Neurobiology of Tourette Syndrome and Related Disorders

Study of Fluoxetine in Patients With Depersonalization Disorder

Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study

Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients

Use of a Traumatic Brain Injury (TBI) Screen in a Veteran Mental Health Population

Improving Care, Accelerating Recovery and Education

Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders

Psychiatric Advance Directives for Improved Mental Health Care

Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study

Computational Psychiatric Approach to Depression

Dialectical Behavior Therapy for Justice-Involved Veterans

Phase I/II Study of Neuroendocrine Dysfunction in Patients With Closed Head Injuries